Johnson & Johnson announced definitive agreement to acquire Cougar Biotechnology. The company will initiate a tender offer to buy all outstanding shares of Cougar Biotechnology at $43 per share. The Boards of both Johnson & Johnson and Cougar Biotechnology have ­approved the transaction. The deal is expected to close in the third quarter of 2009.